LingVo.club
📖+20 XP
🎧+15 XP
+25 XP
New Oral Drug Candidate for Measles and Parainfluenza (Level A2) — Docks with colorful boat covers at galilee harbor

New Oral Drug Candidate for Measles and ParainfluenzaCEFR A2

26 May 2026

Adapted from LaTina Emerson-Georgia State, Futurity CC BY 4.0

Photo by Sheila C, Unsplash

Level A2 – High beginner / Elementary
2 min
85 words

Researchers reported a new oral antiviral candidate called GHP-88310. They tested the compound in animal models, including rodents and larger mammals, and in human airway cell cultures.

The team focused first on human parainfluenza type 3, a virus that can cause serious pneumonia in older and vulnerable people. There are currently no vaccines or approved treatments for this parainfluenza disease. The study also notes measles as a second possible use because measles cases have re-emerged in parts of the US, Mexico and Canada.

Difficult words

  • antivirala medicine that fights virus infections
  • candidatea thing being tested for medical use
  • compounda chemical substance made of two or more parts
  • animal modelan animal used to study a disease or treatment
    animal models
  • rodenta small mammal like a mouse or rat
    rodents
  • airwaythe path that air follows into the lungs
  • pneumoniaa lung infection that makes breathing hard

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Why do researchers test new medicines in animals and cell cultures before people?
  • Who can get serious pneumonia from parainfluenza according to the article?
  • Why might measles be a possible use for this drug according to the text?

Related articles

Family support and health in Europe (Level A2)
26 Dec 2025

Family support and health in Europe

A study of more than 38,000 adults across Europe looked at help between family generations and its links to physical and mental health. Researchers found complex patterns and say more research is needed to understand the effects.